Abstract 4765: MERTK is a potential therapeutic target in osimertinib-resistant non-small cell lung cancer
Year: 2019
Type: conference-abstract
Source: Cancer Research
Institution: Children's Healthcare of Atlanta
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4246462312
